Naploy NPLY
Naploy reports $18,097 revenue and $31,676 net loss for fiscal 2026
- Form
- 10-K
- Filed
- Importance
- Notable
- Accession
- 0001683168-26-008168
- Revenue of $18,097 for the year ended Jul 31, 2026
- Net loss of $31,676 for the year ended Jul 31, 2026
- Diluted EPS of -$0.01 for the year ended Jul 31, 2026
- Cash and equivalents of $20,228 as of Jul 31, 2026
Written from the 10-K on EDGAR. Check the filing before you rely on it.
What changed
4 changes since the July 2025 10-K
Compared with the 10-K 0001683168-25-007786, filed Oct 27, 2025.
Cash up 59% from Jul 31, 2025
$20.2K, was $12.7K.
From the filings
Before
$12.7KNow
$20.2KNet income down 53% from Jul 31, 2025
−$31.7K, was −$20.7K.
From the filings
Before
−$20.7KNow
−$31.7KJuly 31, 2026 compared to the fiscal year ended July 31, 2025.
Adds "2026"; drops "2025".
From the filings
Before
July 31, 2025 compared to the fiscal year ended July 31, 2024. This increase during the period was primarily due to: increased audit fees and legal fees.Now
July 31, 2026 compared to the fiscal year ended July 31, 2025. This increase during the period was primarily due to higher general and administrative expenses, driven primarily by an increase in consulting fees.$21,162 for the year ended July 31, 2026, comprised of amounts due to related-party.
Adds "$21,162"; drops "$1,537".
From the filings
Before
$1,537 for the year ended July 31, 2025, comprised of proceeds from related party loans of $162 and proceeds from sale of common stock of $1,375.Now
$21,162 for the year ended July 31, 2026, comprised of amounts due to related-party.
Show the redline
Section by section. Added words and removed words against the earlier filing.
Cover page 13 changes
2 unchanged paragraphs
Annual Report pursuant to Section 13 or
Transition Report pursuant to Section 13
Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended July 31 , 2025 2026
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
1 unchanged paragraph
Registration No. 333-274889
Registration No. 000-56729
1 unchanged paragraph
Primary Standard Industrial
Incorporation or Organization
Classification Code Number
(State or Other Jurisdiction of Incorporation or Organization )
(IRS Employer Identification Number )
7 unchanged paragraphs
Ordinary shares, par value $0.0001 per share
29 unchanged paragraphs
Cybersecurity 1 change
2 unchanged paragraphs
During the fiscal year ended July 31, 2025, 2026, the
3 unchanged paragraphs
Mine safety disclosures 4 changes
1 unchanged paragraph
As of July 31, 2025, 2026, no shares of our common stock
2 unchanged paragraphs
As of July 31, 2025, 2026, the 3,803,370 issued and
outstanding shares of common stock were held by a total of 51 52 shareholder of record.
1 unchanged paragraph
stock during the fiscal years ended July 31, 2025 2026 and 2024. 2025.
3 unchanged paragraphs
MD&A 23 changes
6 unchanged paragraphs
During the years ended July 31, 2025 2026 and 2024, 2025,
we generated $18,097 and $7,950 of revenue, respectively. Revenue increased by $10,147, or 127.6%, for the fiscal year ended July 31,
we generated $7,950 and $0 of revenue, respectively. Revenue increased by $7,950, or 100%, for the fiscal year ended July 31, 2025 2026 compared to the fiscal year ended July 31, 2024. 2025. This increase in revenue was due to start of sales of our services in October 2024.
1 unchanged paragraph
31, 2025 2026 and 2024, 2025, were $28,664 $49,773 and $20,301, $28,664, respectively, which were comprised of amortization expense ($9,000 - July 31, 2025 2026 and $9,000
- July 31, 2024); 2025); general and administrative fees of the Company ($88 ($21,064 July 31, 2025 2026 and $273 $88 - July 31, 2024); 2025); and professional fees ($19,576 ($19,709 - July 31, 2025 2026 and $11,028 $19,576 - July 31, 2024). 2025). Operating expenses increased by $8,363, $21,108, or 41.2%, 73.6%, for the fiscal year ended
July 31, 2025 2026 compared to the fiscal year ended July 31, 2024. 2025. This increase during the period was primarily due to increased audit fees higher general and legal administrative expenses, driven primarily by an increase in consulting fees.
of the above, the Company recorded a net loss of $20,714 $31,676 and $20,301 $20,714 for the years ended July 31, 2025 2026 and 2024, 2025, respectively.
1 unchanged paragraph
As of July 31, 2025, 2026, we had
had total assets were $59,342, $57,853, comprised of $32,717 $40,228 in current assets and $26,625 $17,625 in intangible assets. As of July 31, 2025, 2026, our current liabilities were $70,470 $100,657 and stockholders equity deficit was $11,128. $42,804.
As of July 31, 2025, we
had total assets were $59,342, comprised of $32,717 in current assets and $26,625 in intangible assets. As of July 31, 2025, our current liabilities were $70,470 and Stockholders equity was $11,128.
1 unchanged paragraph
of cash for the years ended July 31, 2025 2026 and 2024 2025 were as follows:
2 unchanged paragraphs
Net Cash Provided by (Used in) Investing Activities
2 unchanged paragraphs
We used net cash of $21,165 $13,651
in operating activities for the year ended July 31, 2025, 2026, as a result of our net loss of $20,714 $31,676 adjusted for non-cash amortization in the amount of $9,000, increase in prepaid expenses of $20,000, increase in accounts payable of $99 $121 and increase in deferred revenue of net cash of $17,001 in operating activities for the year ended July 31, 2024, as a result of our net loss of $20,301 adjusted for non-cash amortization in the amount of $9,000, decrease in accounts payable of $5,700. $8,904.
In comparison, we used
net cash of $17,001 in operating activities for the year ended July 31, 2025, as a result of our net loss of $21,165 adjusted for non-cash amortization in the amount of $9,000, increase in prepaid expenses of $20,000, increase in accounts payable of $99 and increase in deferred revenue of $10,450.
1 unchanged paragraph
the year ended July 31, 2025. For the year ended July 31, 2024, we have generated $(20,000) in investing activities.
We had no cash provided by (used in) investing activities for
activities for the years ended July 31, 2026 and 2025.
2 unchanged paragraphs
$1,537 for the year ended July 31, 2025, comprised of proceeds from related party loans of $162 and proceeds from sale of common stock of $1,375.
$21,162 for the year ended July 31, 2026, comprised of amounts due to related-party.
1 unchanged paragraph
activities was $68,451 $1,537 for the year ended July 31, 2024, 2025, comprised of proceeds from related party loans amounts due to related-party of $33,759 $162 and proceeds from sale of common stock of $34,692. $1,375.
13 unchanged paragraphs
Financial statements 82 changes
1 unchanged paragraph
Balance Sheet as of July 31, 2025 and 2024
Report of Independent Registered Public Accounting Firm (ID: 6993)
Balance Sheets as of July 31, 2026 and 2025
Statements of Operations for the years ended July 31, 2025 2026 and 2024 2025
Statements of Stockholders Equity for the years ended July 31, 2025 2026 and 2024 2025
Statements of Cash Flows for the years ended July 31, 2025 2026 and 2024 2025
5 unchanged paragraphs
Company as of July 31, 2025, and 2024 and the results of its operations and its cash flows for each of the two years in the period ended
of Naploy Corp. as of July 31, 2025, 2026, and 2024 2025 and the related statements of operations, stockholders equity, and cash flows for each of the two years in the period ended July 31, 2025 2026 and 2024, 2025, and the related notes (collectively referred to as the financial statements ). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of July 31, 2026, and 2025 and the results of its operations and its cash flows for each of the two years in the period ended July
July 31, 2025, 2026, and 2024 2025 in conformity with accounting principles generally accepted in the United States of America.
1 unchanged paragraph
prepared assuming the Company will continue as a going concern as disclosed in Note 2 to the financial statement, the Company incurred a net loss of $(20,714) $31,676 and an accumulated deficit of $(47,395) $79,071 . The continuation of the Company as a going concern is dependent upon continuing financial support from its stockholders and lenders. Management believes the existing shareholders or external fund providers will provide the additional cash to meet the Company s obligations as they become due.
8 unchanged paragraphs
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
9 unchanged paragraphs
We evaluated management s plan for addressing the adverse effects of the conditions identified, including assessing the reasonableness of forecasted information and underlying assumptions by comparing to actual results of prior periods and actual results achieved to date, and utilizing our knowledge of the entity, its business and management in considering liquidity needs and the Company s ability to generate sufficient cash flow, (iii)
We assessed the possibility of raising additional debt or credit, (iv) We evaluated the completeness and accuracy of disclosures in the financial statements.
We evaluated the completeness and accuracy of disclosures in the financial statements.
5 unchanged paragraphs
Accounts Payable Related Party
Amounts Due to Related-Party
1 unchanged paragraph
Common stock, $ 0.0001 par value, 75,000,000 shares authorized; 3,803,370 and 3,734,620 3,803,370 shares issued and outstanding as of July 31, 2025 2026 and July 31, 2024, 2025, respectively
5 unchanged paragraphs
STATEMENT STATEMENTS OF OPERATIONS
Years ended July 31, 2025 2026 and 2024 2025
9 unchanged paragraphs
STATEMENT STATEMENTS OF STOCKHOLDERS EQUITY
Years ended July 31, 2025 2026 and 2024 2025
Balance, July 31, 2025
Net loss for the year ended July 31, 2026
Balance, July 31, 2026
4 unchanged paragraphs
Balance, July 31, 2023
Shares issued for cash
Net loss for the year ended July 31, 2024
Balance, July 31, 2024
3 unchanged paragraphs
Years ended July 31, 2025 2026 and 2024 2025
3 unchanged paragraphs
CASH FLOWS FROM INVESTING ACTIVITIES
Mobile Application and Website Acquisition
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES
1 unchanged paragraph
Accounts Payable - Related Party Loans
Amounts Due to Related-Party
11 unchanged paragraphs
YEARS ENDED JULY 31, 2025 2026 AND 2024 2025
7 unchanged paragraphs
Company had an accumulated deficit of $ 47,395 79,071 as of July 31, 2025 2026 a net loss of $ 20,714 31,676 for the year ended July 31, 2025. 2026. These factors raise substantial doubt about the Company s ability to continue as a going concern.
20 unchanged paragraphs
Our cash is held in a Wise electronic money
account. In accordance with ASC 230-10-20, Statement of Cash Flows , the Company has determined that the cash held in the Wise electronic money account should be classified as cash because it is readily available for the payment of obligations, and free from any contractual restriction that limits its use.
Our Company holds its cash and cash equivalents
in accounts with Wise, a financial technology company specializing in international money transfers. It is important to note that Wise is not a bank, but rather a licensed and regulated financial services provider.
Wise operates under regulatory frameworks and
is subject to oversight by various financial regulatory authorities. While it provides services that are similar to traditional banks, it does not operate as a traditional bank and is not a member of the Federal Deposit Insurance Corporation (FDIC).
Investors should be aware that, unlike traditional
banks covered by the FDIC, Wise accounts do not offer deposit insurance. The absence of FDIC coverage means that the funds held in Wise accounts are not protected up to the standard FDIC-insured limit.
Our cash is held exclusively in a Wise electronic
money account. Funds held in Wise accounts are not insured by the Federal Deposit Insurance Corporation (FDIC) or any other deposit protection scheme.
Over 99% of Wise s funds are held in cash
with these banks (GOLDMAN SACHS BANK USA, JPMORGAN CHASE BANK, N.A., WELLS FARGO BANK, N.A., US Government bonds) as well as in secure liquid assets such as EU, UK and US Government bonds in order to diversify risk and maximise liquidity. Wise takes this approach to make sure the money is highly liquid and therefore always available to clients.
Our choice to utilize Wise aligns with our commitment
to leveraging innovative and efficient financial services while remaining transparent about the associated regulatory and insurance considerations.
As the company is incorporated in and under the
laws of the United States, we are considered as the American customer of Wise and fall under the jurisdiction of the agreement for the
2 unchanged paragraphs
2025. 2026. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
28 unchanged paragraphs
As of July 31, 2025 2026 and 2024, 2025, there were no potentially
5 unchanged paragraphs
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ( CODM ), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. This ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company adopted the ASU and determined that its adoption did not have a material impact on the Company s financial statements and related disclosures. As defined in the
ASU, operating segments are components of an enterprise about which discrete financial information is regularly provided to the CODM in making decisions on how to allocate resources and assess performance for the organization. This standard was effective for the Company for the year ended July 31, 2025, and did not have a material impact on the Company s financial statements (see Note 4).
In September 2025, the FASB issued ASU 2025-06,
Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use
Software," which modernizes the accounting for costs related to internal-use software by removing all references to prescriptive and sequential software development stages. The amendments are effective for fiscal years beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the ASU to determine its impact on the Company s disclosures and consolidated financial statements.
In November December 2023, the FASB issued ASU 2023-07, 2023-09,
"Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which enhances the disclosure requirements for income taxes primarily related to the rate reconciliation and income taxes paid information. The amendments are effective for fiscal years beginning after December 15, 2024. The Company adopted the standard on a prospective basis for the fiscal year ended July 31, 2026. The required disclosures are included in Note 8.
9 unchanged paragraphs
31, 2025 and 2024, respectively.
NOTE 6 LOAN FROM RELATED PARTY
As of July 31, 2025, the Company had a loan outstanding
with a related party: Mr. Rafael Angel Ulloa Bonilla, our Director, who has given us a loan in the amount of $ 59,921 for the Company s working capital purposes. The amount is outstanding and payable upon request.
and website for $ 45,000 , which is being amortized over a five-year five -year life. The accumulated amortization was $ 18,375 27,375 and $ 9,375 18,375 as of July
31, 2026 and 2025, respectively.
NOTE 6 RELATED PARTY TRANSACTIONS
As of July 31, 2026, the amount due to the Company s
Director, Mr. Rafael Angel Ulloa Bonilla, was $ 81,083 , which consists of $ 60,083 of operating expenses the director paid on behalf of the Company for the period from April 6, 2023 (inception) through July 31, 2026, and $ 21,000 the services provided by the Director to the Company for the year ended July 31, 2026.
7 unchanged paragraphs
On December 22, 2017, the President of the United
States signed into law the Tax Cuts and Jobs Act ( Tax Reform Act ). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. As a result of the reduction in the U.S. corporate income tax rate from 34% to 21% under the Tax Reform Act, the Company revalued its ending net deferred tax assets.
As of July 31, 2025, 2026, and July 31, 2024, 2025, the Company
had 3,803,370 and 3,734,620 3,803,370 shares issued and outstanding, respectively.
For the year ended July 31, 2026, the Company has incurred net losses and therefore, has no tax liability. The cumulative net operating loss carry-forward is approximately $ 79,071 as of July 31, 2026, and will expire beginning in the year 2037.
1 unchanged paragraph
at the U.S. statutory rate at 21% for the period year ended July 31, 2026 and 2025, as follows:
Schedule of reconciliation of income tax reconciliation benefit (expenses)
4 unchanged paragraphs
Schedule of deferred income taxes
Schedule of net deferred tax assets
1 unchanged paragraph
2 unchanged paragraphs
and 2 more changes in the filing
Controls and procedures 5 changes
5 unchanged paragraphs
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer at the time, the Company conducted an evaluation of the effectiveness of the Company s internal control over financial reporting as of July 31, 2025, 2026, using the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
2 unchanged paragraphs
of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of July 31, 2025, 2026, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.
1 unchanged paragraph
The Company lacks appropriate information technology controls As of July 31, 2025, 2026, the Company retains copies of all financial data and material agreements; however, there is no formal procedure or evidence of normal backup of the Company s data or off-site storage of data in the event of theft, misplacement, or loss due to unmitigated factors.
3 unchanged paragraphs
above, management has concluded that the Company did not maintain effective internal control over financial reporting as of July 31, 2025, 2026, based on criteria established in Internal Control- Integrated Framework issued by COSO in 2013.
3 unchanged paragraphs
On July 31, 2026, under the supervision and with the participation of our management at the time, an evaluation was conducted of the effectiveness of the design and operation of our disclosure controls and procedures as of July 31, 2025. 2026. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.
3 unchanged paragraphs
Other information 1 change
year ended July 31, 2025, 2026, no director or officer of the Company adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.
Management 4 changes
13 unchanged paragraphs
Frederick Sidney Reinhard Arnold, Age 39 40
8 unchanged paragraphs
in accounting and finance, attended pre-medical school and has medical degree, showcasing a unique blend of financial acumen and medical insight. He has been working in administrative department of Consultorio del Dr. Edwin Chan hospital for ten years until the 2000s and played a crucial role in coordinating day-to-day activities, optimizing workflow, and ensuring efficiency. For the past 5 years has worked independently, engaging in traditional medical advice and providing his services in his private office called "Acupuncture & herbal medicine cabinet". Committed to holistic well-being, he has attended various medical trainings to enhance his knowledge and offer valuable insights to those seeking alternative healthcare solutions. In addition, he was a part of a group collecting the information for a book on various treatments, from traditional to modern medicine. His reputation is built on his wide experience, ability to think creatively, devise strategic plans, and exhibit outstanding leadership qualities. Through his unwavering dedication and perseverance, he has steered these enterprises towards remarkable achievements. Now, he aims to utilize his extensive expertise as the Director of the Company.
There are no any parent, subsidiary or other affiliates of the Company especially in which any of the directors could have previous occupation.
of the Company especially in which any of the directors could have previous occupation.
12 unchanged paragraphs
Executive compensation 3 changes
5 unchanged paragraphs
Long-term, Stock Based
2 unchanged paragraphs
Granting of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information
We do not grant Granting of Certain Equity Awards Close in Time to the Release of awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock, and do not time the public release of such information based on award grant dates. During the last completed fiscal year, we have not made awards to any named executive officer or director during the period beginning four business days before and ending one business day after the filing of a period report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K, and we have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.
Principal stockholders 6 changes
1 unchanged paragraph
information relating to the beneficial ownership of our common stock as of July 31, 2025, 2026, by:
5 unchanged paragraphs
Amount and Nature of Beneficial Ownership
1 unchanged paragraph
Beneficial Ownership
3 unchanged paragraphs
any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares:
A beneficial owner of a security includes any
person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the number of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the person s actual ownership or voting power with respect to the number of shares of common stock actually outstanding on July 31, 2025. 2026. As of July 31, 2025, 2026, there were 3,803,370 shares of our common stock issued and outstanding.
Related-party transactions 4 changes
2 unchanged paragraphs
As of July 31, 2025, the Company had a loan outstanding
with a related party: Mr. Rafael Angel Ulloa Bonilla, our Director, who has given us a loan in the amount of $59,921. The loan is non-interest bearing, due upon demand and unsecured. No principal of this loan has been repaid yet. Loan agreement is filled as an Exhibit 10.1 to this Registration Statement. This Agreement is governed by the laws of the State of Wyoming.
As of July 31, 2026, the amount due to the Company s
Director, Mr. Rafael Angel Ulloa Bonilla, was $81,083, which consists of $60,083 of operating expenses the director paid on behalf of the Company for the period from April 6, 2023 (inception) through July 31, 2026, and $21,000 the services provided by the Director to the Company for the year ended July 31, 2026.
Principal accounting fees and services 1 change
1 unchanged paragraph
to us by our independent auditors (Boladale Lawal & Co) and our former independent auditors (BFBorgers CPA PC) for professional services rendered related to the fiscal years ended July 31, 2025, 2026, and July 31, 2024: 2025:
8 unchanged paragraphs
Form 10-k summary 4 changes
3 unchanged paragraphs
Dated: October 27, 2025
Dated: October 30, 2026
6 unchanged paragraphs
Dated: October 27, 2025
Dated: October 30, 2026
2 unchanged paragraphs
Unchanged: Risk factors, Unresolved Staff Comments, Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities, [Reserved], Disclosure Regarding Foreign Jurisdictions that Prevent Inspections, Business, Properties, Legal proceedings, Market risk, Changes in and disagreements with accountants, Disclosure regarding foreign jurisdictions, Exhibits
Compared by code from the two filings' text and XBRL. Not advice.
The reading, claim by claim
- The company's primary business is a news blog focused on health-related topics, including medical breakthroughs and healthcare policies.
- It also operates a mobile app called Naploy App, which provides health news and information.
- The company has not generated sufficient revenue and has incurred losses since its inception.
- The company's app offers online information help services for finding medical institutions.
4 of 5 claims matched the filing text.
Not found in the filing text
- The filing reports revenue of $18,097 and a net loss of $31,676.
From the filing
ITEM 1. BUSINESS.
ITEM 1. BUSINESS.
DESCRIPTION OF BUSINESS GENERAL
Naploy Corp. (referred as the Company , we , our ) was incorporated in the State of Wyoming and established on April 6, 2023. The Company has no sufficient revenue and has incurred losses since inception.3 Our primary focus is on launching a news blog that provides the latest updates on health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies.1 We have developed a full business plan.
Currently, we have no employees, only our officers and Directors - Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla. Our executive and business office is located at 95 Lias Estate Kafe district Abuja, FCT 900108 Nigeria, and our telephone number is +13072133163.
The COVID-19 pandemic has had a significant impact on the healthcare industry and has led to changes in the way healthcare services are delivered, including through mobile applications that offer online information help services for finding medical institutions.4 Here are some ways the pandemic has affected these types of apps:
Increased demand: The pandemic has increased the demand for healthcare services, and many people have turned to mobile apps to find information about medical institutions and services.
Safety concerns: Many people are hesitant to visit medical institutions in person due to safety concerns, and mobile apps that offer information about medical institutions and their safety protocols can help alleviate these concerns.
Our Naploy App is your go-to source for the latest health news and updates.2 Naploy App offers an article library- News Blog that deals with the most common health topics. Our health blog covers diverse health related concerns such as nutrition and diet, fitness, weight control, diseases, disease management, societal trends affecting health, analysis about health, business of health and health research. The app is available for both Android and iOS mo
Similar companies
Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.
- Alps Group ALPS
- American Oncology Network AONC
- Agape ATP ATPC public float $5M, Dec 31, 2025
- Anew Health AVG
- Better Therapeutics BTTX